- Home
- EXEL vs PNW Comparison
EXEL vs PNW Comparison
Compare EXEL & PNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EXEL | PNW |
|---|---|---|
| Founded | 1994 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Electric Utilities: Central |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.1B | 10.6B |
| IPO Year | 2000 | N/A |
Fundamental Metrics
Financial Performance| Metric | EXEL | PNW |
|---|---|---|
| Price | $41.94 | $88.99 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 24 | 12 |
| Target Price | $45.18 | ★ $96.27 |
| AVG Volume (30 Days) | ★ 2.6M | 1.2M |
| Earning Date | 11-04-2025 | 11-03-2025 |
| Dividend Yield | N/A | ★ 4.14% |
| EPS Growth | ★ 53.55 | N/A |
| EPS | 2.38 | ★ 4.92 |
| Revenue | $2,288,218,000.00 | ★ $5,307,180,000.00 |
| Revenue This Year | $9.84 | $4.78 |
| Revenue Next Year | $11.92 | $4.15 |
| P/E Ratio | ★ $17.50 | $17.86 |
| Revenue Growth | ★ 9.93 | 5.70 |
| 52 Week Low | $31.90 | $81.47 |
| 52 Week High | $49.62 | $96.50 |
Technical Indicators
Market Signals| Indicator | EXEL | PNW |
|---|---|---|
| Relative Strength Index (RSI) | 50.02 | 52.91 |
| Support Level | $40.83 | $87.36 |
| Resistance Level | $42.09 | $88.56 |
| Average True Range (ATR) | 1.05 | 1.11 |
| MACD | -0.32 | 0.07 |
| Stochastic Oscillator | 30.00 | 58.66 |
Price Performance
Historical ComparisonAbout EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
About PNW Pinnacle West Capital Corporation
Pinnacle West is a holding company whose principal subsidiary is Arizona Public Service, a vertically integrated electric utility serving approximately 1.4 million customers across a 35,000-square-mile territory in central Arizona, including the Phoenix area. APS owns or leases 6.5 gigawatts of power generation capacity, including a 29% ownership stake in one of the largest nuclear plants in the US, Palo Verde. Half of the electricity that APS supplies to customers comes from clean energy sources, including nuclear.